A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results.
Coronel
Jaime
J
Division of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico.
Cetina
Lucely
L
Pacheco
Irlanda
I
Trejo-Becerril
Catalina
C
González-Fierro
Aurora
A
de la Cruz-Hernandez
Erick
E
Perez-Cardenas
Enrique
E
Taja-Chayeb
Lucia
L
Arias-Bofill
Daymi
D
Candelaria
Myrna
M
Vidal
Silvia
S
Dueñas-González
Alfonso
A